Tirzepatide's Association With BP Reduction Reinforced With ABPM Data

(MedPage Today) -- The once-weekly injectable tirzepatide (Mounjaro, Zepbound) was associated with reduced blood pressure (BP) in a prospective substudy of the SURMOUNT-1 trial. Depending on the dose of the combination glucagon-like peptide-1...

https://www.medpagetoday.com/cardiology/hypertension/108579

Source: MedPage Today Primary Care - February 5, 2024 Category: Primary Care Source Type: news

More News: Primary Care